Cell Based Assay Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Cell-based assays consists a variety of assays that measure cellular parameters such as proliferation, cell toxicity, production of markers, motility, activation of specific signalling pathways and changes in morphology. The cell-based assay market is driven by the increased adoption of high throughput screening methods, increasing investments in drug discovery, increase in the cell-based research activities, rapid technological advances, non-invasive methods of monitoring and the development in the automation.

Cell-Based Assay Market Segments Size & Growth:

Cell-Based Assay Market is expected to increase by a $ 10.619 billion by 2024 at a CAGR of 16.5%. Increasing research activities in drug discovery, the rise in demand for biological drugs, technological advancement, government expenditure, rising need for toxicity screening in drugs are expected to fuel the market for cell-based assays. However, need to reduce the cost associated the drugs, and technical advancements in innovations are expected to drive the market growth. Cell-based assay market is restrained by the lack of skilled personnel and high on maintenance and operational costs.

Cell-Based Assay Market Segments Share:

Cell-Based Assay market is segmented into the type of products which includes cell lines, ligands & Inhibitors and cell culture kits, reagents & consumers. Among these cell lines holds the most significant share due to the presence of different varieties of cell lines. Based on the technology, cell-based assay market flow cytometry, high content screening, label-free detection and others. Application segment includes drug discovery and ADME Research and others. Adoption of high throughput screening methods and increase in the ADME research investments expected to fuel the market growth.

Based on end-user cell-based assay approach is further subdivided into biotechnology, pharmaceuticals, academia and CRO. Based on geography, North America holds the most significant share in the global cell-based assay market due to the growing availability of funds for research and resilient drug discovery activities in the countries like the US. The Asia Pacific is anticipated to experience the rapid growth regarding the use of cell-based assay and development.  Increase in awareness about the assays for drug discovery, the rise in cell-based assay applications and others are the factors for the growth in this region.

Cell-Based Assay Market Trends:

• NanoBRET target engagement intracellular kinase assay was launched by the Promega to demonstrate the potency and selectivity of kinase inhibitors in living cells.
• Mammography system was launched by the GE healthcare that allows patients to control their compression by remote control.
• Volar Glass new packaging line getting manufactured by the Corning by Governor Cuomo.
• AMETEK, Inc acquired creaform Inc a leading manufacturer and developer of innovative portable 3D measurement technologies.

Cell-Based Assay Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

• Ametek, Inc
• Promega Corporation
• GE Healthcare
• Corning, Inc
• Bio-Rad Laboratories